March 24, 2025
Why Your Brain Tricks You Into Wanting Sugar During Detox
Read More
Drug Rehab Success Rates: What the Data Actually Shows (2025)
Start your road to recovery in a comfortable, serene, and compassionate space. Bright Futures Treatment Center offers you the opportunity to make a fresh start.
Published:May 17. 2026
One-year abstinence rates after rehab range from 41% for alcohol to around 29% for heroin — but those numbers tell only part of the story. How someone uses their drug matters as much as which drug they use: people taking opioids orally are 30% more likely to be abstinent one year later than those who inject. Program length, aftercare, and dual diagnosis treatment are the factors that most reliably improve outcomes across all substances. Relapse is common in recovery, comparable in frequency to conditions like hypertension, but it does not mean treatment failed. It means recovery is a process, not a single event.
If you are trying to understand drug rehab success rates for yourself or someone you care about, the honest answer is: it depends, and the data now exists to say on what. Bright Futures Treatment Center, a substance abuse treatment center in Florida, has based its treatment programs on this evidence for years. The numbers below come from a 2025 study by Vista Research Group that followed 10,000 patients for one year after discharge — the most rigorous dataset available on this question. They paint a more nuanced picture than simple pass/fail.
One-Year Abstinence Rates by Substance
The following data is drawn from Vista Research Group’s 2025 analysis of 10,000 patients followed for one year after completing addiction treatment. Abstinence is defined as no use of alcohol or non-prescribed drugs for at least the last 30 days at the one-year mark.
Substance 1-Year Abstinence Key Factor Alcohol 41% Highest success; AA and MAT significantly improve outcomes Amphetamines 40% Similar to alcohol; behavioral therapy most effective Marijuana 38% 6.6% relapse over ~3.6 years after initial recovery Prescription Opioids (oral) 35% 54% of users take orally — better outcomes than injection Benzodiazepines 30–40% Gradual tapering required; abrupt stopping dangerous Fentanyl ~31% Only 12% inject — better outcomes than heroin despite potency Cocaine 29–39% Up to 79% avoid weekly use after a 90-day program Methamphetamine 29–31% 61% relapse within first year Heroin ~29% 51% inject — lowest abstinence rate of all substances
Why the Numbers Look the Way They Do
The gap between alcohol (41%) and heroin (29%) is real, but it is not primarily explained by the substances themselves. It is largely explained by how people use them. This is one of the most important findings in the Vista data and one that rarely gets the attention it deserves.
Method of Use Changes Everything for Opioids
For opioid users, the route of administration is one of the strongest predictors of outcome. One year after treatment:
- Those taking opioids orally: 35% abstinence rate
- Those inhaling or snorting: 33%
- Those smoking: 30%
- Those injecting: 27%
That is a 30% difference in outcomes between oral and injection use — a gap larger than the difference between alcohol and heroin users overall. The reason fentanyl users actually outperform heroin users in abstinence rates (31% vs 29%) despite fentanyl being more potent is simply that only 12% of fentanyl users inject, compared to 51% of heroin users.
Earlier intervention matters enormously here: 37% of oral opioid users had been using problematically for under two years, compared to only 21% of those who were injecting. The sooner someone enters fentanyl addiction treatment, the less likely they are to have progressed to injection use, and the better their chances.
Why Relapse Does Not Mean Failure
Relapse rates of 40–60% sound alarming until you compare them to other chronic health conditions. Hypertension and asthma have similarly high non-adherence and symptom-return rates. Drug addiction is a chronic condition, not an acute one — a single treatment episode rarely resolves it permanently. What treatment does is reduce harm, stabilize health, and create the conditions for long-term recovery. The risk is highest in the first three months after treatment ends, which is why the quality of aftercare in that window matters as much as the treatment program itself.
NOTE: Success in addiction recovery is better measured by reduced harm, improved quality of life, and sustained engagement with support — not by a single abstinence data point. The numbers in this article are useful benchmarks, not verdicts. For a broader picture, see our guide on long-term sobriety outcomes.
Substance-by-Substance Breakdown
Alcohol
Alcohol has the highest one-year abstinence rate at 41%, and outcomes improve further with evidence-based support. MAT options, including naltrexone and acamprosate, reduce cravings and relapse risk, while peer support programs like AA have decades of outcome data behind them. Bright Futures’ alcohol rehab program combines these approaches with individual therapy and structured outpatient care.
Opioids and Fentanyl
Opioid addiction is where medication-assisted treatment (MAT) makes the most measurable difference. Despite this, only 12% of outpatient opioid patients complete MAT — a significant gap between what works and what gets used. Medications like buprenorphine and naltrexone reduce cravings and prevent overdose, and their use is associated with meaningfully better one-year outcomes.
Stimulants — Cocaine and Methamphetamine
Stimulant addiction presents different challenges than opioids. There are no equivalent MAT options, so treatment relies on behavioral approaches — particularly contingency management, which uses structured incentives to reinforce abstinence, and CBT.
Methamphetamine has one of the highest relapse rates at 61% within the first year. Cocaine shows more variability: one-year non-weekly use rates of up to 79% after a 90-day program suggest that longer, more intensive treatment has a significant effect. Our meth rehab programs and crack cocaine treatments address stimulant addiction through evidence-based behavioral therapy.
Marijuana
Marijuana has a 38% one-year abstinence rate and the lowest long-term relapse rate in the Vista data — 6.6% relapse over approximately 3.6 years among those who achieved initial recovery. Withdrawal symptoms are primarily psychological rather than physical, making the acute phase of treatment more manageable. Marijuana treatment typically involves motivational interviewing and CBT to address the psychological patterns of use.
Benzodiazepines and Prescription Drugs
Benzodiazepine addiction is among the most medically complex to treat because abrupt cessation carries genuine physical risk, including seizures. Gradual tapering under medical supervision is non-negotiable, and outcomes improve significantly with long-term monitoring. Our prescription drugs addiction treatment programs are designed around exactly this kind of structured, supervised reduction.
What Actually Moves the Needle: Factors That Predict Success
The substance is not the only variable. These factors consistently predict better outcomes across all drugs in the research literature:
- Program length: 90-day programs consistently outperform 30-day programs across all substances. The data on this is unambiguous.
- Aftercare participation: one of the strongest single predictors of sustained recovery. What happens in the first three months after treatment ends often determines long-term outcomes more than what happened during treatment.
- Dual diagnosis treatment: programs that treat co-occurring mental health conditions alongside addiction achieve 50–70% success rates. Trauma-focused care addresses depression, anxiety, PTSD, and trauma that directly affect relapse risk if left untreated.
- MAT for opioids: medication-assisted treatment reduces relapse risk significantly, yet only 12% of outpatient opioid patients complete it. Closing that gap is one of the clearest opportunities to improve outcomes.
- Method of use: oral opioid users have a 35% abstinence rate at one year versus 27% for those injecting — a 30% difference driven by how far the addiction has progressed, not the substance itself.
- Treatment completion: approximately 70% of Florida patients complete their programs, which is above the national average and a meaningful predictor of better outcomes.
- Early intervention: 37% of oral opioid users had been using problematically for under two years, compared to only 21% of injectors. The earlier treatment begins, the less likely the use has escalated to injection, and the better the prognosis.
The dual diagnosis finding is particularly significant: 50 to 70% success rates when mental health is treated alongside addiction, compared to much lower rates when only the substance use is addressed. This is why integrated care matters.
Rehab Success Rates in South Florida: What to Know
South Florida has one of the highest concentrations of treatment facilities in the country, which means the quality and outcomes vary significantly depending on how you choose a program. Florida treatment data show that approximately 70% of patients complete their programs, slightly above national averages, but completion is only meaningful if the program itself is evidence-based.
Broward County and broader South Florida identified the opioid crisis and put opioid addiction as their highest treatment priority in 2022 needs assessments, reflecting the regional scale of the problem. The programs that consistently produce the best outcomes in this region share a few characteristics: evidence-based clinical approaches, integrated mental health support, genuine aftercare structures, and MAT availability where clinically indicated.
NOTE: When evaluating a Florida treatment program, ask specifically about their one-year follow-up data, their dual diagnosis capabilities, and what their aftercare looks like. Programs that cannot answer these questions clearly are worth scrutinizing.
What These Numbers Mean for You
If you are using this data to make a decision, for yourself or someone you love, here is how to read it practically:
- A 41% one-year abstinence rate for alcohol does not mean a 59% failure rate. Many of the remaining 59% will achieve longer periods of sobriety over time, reduce their use significantly, or recover after additional support
- The difference between 29% and 41% across substances is meaningful, but it is not fixed: program quality, treatment length, and aftercare can shift individual outcomes significantly
- Earlier intervention consistently improves outcomes. If someone you care about is using opioids orally, that is the window in which treatment is most likely to succeed before use escalates
- Relapse in the first three months after treatment is the highest-risk period. What happens in that window, specifically, whether someone has structured support, aftercare, and healthy coping strategies, matters enormously.
- MAT for opioids works, and not enough people complete it. If opioid addiction is the issue, finding a program that genuinely integrates MAT and that involves family support throughout the process is one of the most important decisions you can make.
What to Look for in a Treatment Program
Choosing an addiction program based on these outcomes means asking different questions than most people ask. Beyond accreditation and location, the factors that predict better outcomes are:
- Program length of 90 days or more: the data consistently shows longer programs outperform 30-day models across all substances
- Integrated dual diagnosis treatment: co-occurring depression, anxiety, trauma, and PTSD dramatically affect relapse risk when left untreated
- MAT availability for alcohol and opioid addiction: programs that offer medically assisted treatment, where clinically appropriate, have better outcomes
- Structured aftercare with defined follow-up: not just a referral list, but a genuine plan for the first three months post-treatment
- Evidence-based therapies: including CBT, motivational interviewing, and contingency management for stimulants
- The ability to track and share outcome data: programs confident in their results are willing to discuss them
Abstinence rates are one measure of success — but what happens during and after treatment shapes outcomes just as much. These articles cover the practical side of recovery that the data points to but cannot fully capture.Understanding Recovery Beyond the Numbers
Why Rehab Success Is Hard to Measure
One important caveat on all of this drug rehab success rates data: measuring success in addiction treatment is genuinely complex, and the numbers should be read with that in mind. Different programs define success differently: complete abstinence, reduced use, improved functioning, or sustained engagement with support are all legitimate measures. Follow-up periods vary from 30 days to multiple years, and relapse rates naturally increase over longer windows. Self-reporting adds uncertainty, as stigma affects what people disclose. The Vista Research Group data used in this article is among the most rigorous available, but it reflects people who were reachable for follow-up — those who were not reached may have had different outcomes in either direction. We are here to discuss what the data means for your specific situation. Contact us today to speak with someone who can help.
References and Data Sources
The following sources informed the data presented in this article:
- Vista Research Group (2025). Which Addictions Have the Best and Worst Recovery Rates? Based on 10,000 patients followed for one year post-discharge, October 2021–December 2023.
- Florida Department of Children and Families (2022). South Florida substance use treatment needs assessment data
- Leshner, A.I. (2001). Addiction is a brain disease, and it matters. PubMed
- NIDA/NIH. Principles of Drug Addiction Treatment: A Research-Based Guide. ncbi.nlm.nih.gov
FAQs
Which drugs have the highest rehab success rates?
Alcohol has the highest one-year abstinence rate at 41%, followed by amphetamines at 40% and marijuana at 38%. These substances also tend to have lower rates of injection use, which is one of the strongest predictors of outcome.
Why do rehab success rates differ between substances?
Method of use is the biggest factor. People taking opioids orally have a 35% one-year abstinence rate compared to 27% for those injecting. This explains why fentanyl users actually outperform heroin users in outcome data, only 12% of fentanyl users inject compared to 51% of heroin users.
Do relapse rates mean rehab does not work?
No. Relapse is a common feature of chronic conditions — comparable in frequency to non-adherence rates for hypertension and asthma. It signals a need for continued or adjusted support, not that treatment failed. Long-term recovery outcomes improve significantly with structured aftercare and ongoing support.
How much does program length affect success rates?
Significantly. 90-day programs consistently outperform 30-day programs across all substances in the research literature. Longer treatment gives more time for the brain to stabilize, for behavioral patterns to change, and for aftercare structures to be put in place.
What is the highest-risk period after leaving rehab?
The first three months post-treatment carry the highest relapse risk across all substances. Having structured support, regular check-ins, and a clear plan for this period is one of the most reliable ways to improve long-term outcomes.
How does dual diagnosis treatment affect success rates?
Substantially. Programs that treat co-occurring mental health conditions alongside addiction achieve 50–70% success rates compared to significantly lower rates when only substance use is addressed. Depression, anxiety, PTSD, and trauma are common in people with substance use disorder and directly affect relapse risk if left untreated.
Contact Us
Gallery
Get Started